Found 18 matching trials
Safety Tolerability and Pharmacokinetic of BI 411034
PHASE1The primary objective of the current study is to investigate the safety, to...
Location
1308.1.1 Boehringer Ingelheim Investigational Site
Safety Tolerability and Pharmacokinetic of BI 409306
PHASE1The primary objective of the current study is to investigate the safety and...
Location
1289.1.1 Boehringer Ingelheim Investigational Site
Continuous Serratus Anterior Blockade for Sternotomy
NAThis is a pilot study to assess the feasibility of a full study. The purpos...
Location
Nova Scotia Health Authority
First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy Participants
PHASE1This FTIH study aims to evaluate the safety, tolerability and PK of the nov...
Location
GSK Investigational Site
Brain Imaging in the Diabetes Prevention Program Outcomes Study
EARLY_PHASE1This is a cross-sectional pilot study of Alzheimer's disease (AD) brain ima...
Location
Columbia University Irving Medical Center
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects
PHASE1The objective of the current study was to investigate safety, tolerability,...
Location
Multiple Locations
GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers
PHASE1This study is a Phase 1, double-blind (sponsor-unblinded), randomized, plac...
Location
GSK Investigational Site
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers
PHASE1To investigate the safety, tolerability, and pharmacokinetics incl. dose pr...
Location
Multiple Locations
A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
PHASE1This study investigates the safety, tolerability and PKs of GSK2838232 with...
Location
GSK Investigational Site
Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects
PHASE1The primary objective of the current study is to investigate the safety and...
Location
1279.1.1 Boehringer Ingelheim Investigational Site